Go Zero Secures Investment from Namita Thapar on Shark Tank India
Go Zero, the innovative zero-sugar ice cream brand created by Kiran Shah, gained significant attention after his appearance on Shark Tank India Season 4. Recently, Kiran successfully landed an investment deal with Namita Thapar, executive director of Emcure Pharmaceuticals.
Namita took to X to express her enthusiasm for Kiran’s venture and forecasted that Go Zero is likely to reach an annual recurring revenue (ARR) of ₹100 crore this year. What particularly impressed her was the fact that the zero-sugar ice cream brand achieved sales of ₹5 crore in January, typically regarded as an off-peak month for ice cream sales due to the colder winter season in India.
“With sales of ₹5 crore in Jan (the off-season for ice cream), this fabulous Shark Tank founder is on track to do an ARR of ₹100 crore. Ice cream with zero sugar, half the calories & absolutely delicious flavours!” she conveyed on X.
Although Namita did not witness Kiran’s pitch during Shark Tank India Season 4, she was so taken by Go Zero’s accomplishments that she arranged a meeting with him in Pune. Indicating a potential investment opportunity, she disclosed that she had connected with investor Arjun Vaidya for insights.
“I wasn’t there the day he pitched, but I have been a big fan of Kiran Shah & Go Zero (a daily staple in my freezer),” she mentioned, praising the company’s impressive growth. Namita shared that her preferred flavours include raspberry and mango duets.
With Rs 5 crore in sales during January’s off-season for ice cream, Kiran Shah, a standout founder from Shark Tank, is well-positioned to reach an ARR of ₹100 crore. His zero sugar ice cream comes with half the calories and delectable flavours. Kiran Shah’s pitch aimed at making Go Zero the leading ice cream company in India. He valued his company at ₹100 crore and sought ₹1 crore for a 1% stake. Offers poured in from Anupam Mittal, Vineeta Singh, and Aman Gupta, ultimately accepting a deal with Aman for ₹1 crore in return for a 1.5% equity stake.
